Matthew Lamb

Matthew Lamb is an accomplished executive in the biopharmaceutical industry, currently serving as the Executive Vice President & Chief Development Officer at ITB-MED. Previously, Matthew held several senior leadership positions at Bristol Myers Squibb, including Development Head for Immunology & Fibrosis and Vice President of Regulatory Affairs for multiple therapeutic areas. Prior roles include Vice President of Global Regulatory Affairs at Celgene, Actavis plc, and Warner Chilcott, where Matthew contributed to regulatory strategies across various divisions. Matthew's educational background includes a Post-doctoral Fellowship in Clinical Pharmacokinetics & Pharmacodynamics from the University of North Carolina at Chapel Hill and studies at the University of the Sciences in Philadelphia.